Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Toxicology Letters

• Publication date

  2013-06-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.toxlet.2013.03.032PMID 23566899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells.

  2013cited by this paper
• Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results

  2012cited by this paper
• Hepatotoxicity Screening Taking a Mode-Of-Action Approach Using HepaRG Cells and HCA

  2012cited by this paper
• Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line

  2012influential reference
• Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.

  2012cited by this paper
• Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes

  2012influential reference
• Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation

  2012cited by this paper
• Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.

  2012cited by this paper
• Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice.

  2011influential reference
• A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testing

  2011cited by this paper
• Predicting in vivo gene expression in macrophages after exposure to benzo(a)pyrene based on in vitro assays and toxicokinetic/toxicodynamic models.

  2011cited by this paper
• Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products.

  2011influential reference
• HepaRG cells: A human model to study mechanisms of acetaminophen hepatotoxicity

  2011cited by this paper
• Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

  2011cited by this paper
• Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.

  2010cited by this paper
• The vision of toxicity testing in the 21st century: moving from discussion to action.

  2010cited by this paper
• Toxicity Testing in the 21st Century: A Vision and a Strategy

  2010cited by this paper
• Bisphenol A levels in blood depend on age and exposure.

  2009cited by this paper
• Ionization-specific prediction of blood-brain permeability.

  2009cited by this paper
• Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation

  2009cited by this paper
• Quantitative interpretation of human biomonitoring data.

  2008influential reference
• Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

  2007cited by this paper
• Rodgers T, Rowland M. 2006. Physiologically‐based Pharmacokinetic Modeling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238–1257.

  2007cited by this paper
• Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

  2006influential reference
• Pharmaco-metabonomic phenotyping and personalized drug treatment

  2006cited by this paper
• Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain

  2006influential reference
• Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children

  2006influential reference
• An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.

  2005cited by this paper
• Differences in the single‐oral‐dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects

  2005influential reference
• The Binding of Selected Therapeutic Drugs to Human Serum &agr;-1 Acid Glycoprotein and to Human Serum Albumin In Vitro

  2004cited by this paper
• Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.

  2003influential reference
• Absorption kinetics of paracetamol are not influenced by high anxiety levels in preoperative patients.

  2002cited by this paper
• Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of drugs. I: Studies by in vivo constant infusion

  2002cited by this paper
• Prediction of pharmacokinetic properties using experimental approaches during early drug discovery.

  2001cited by this paper
• Physiologically-based pharmacokinetic modeling of pyrene in the rat.

  1998cited by this paper
• MCSim: A Monte Carlo Simulation Program

  1997cited by this paper
• Paracetamol metabolism in two ethnically different Spanish populations

  1996influential reference
• The Analysis of Aquatic Toxicity Data

  1996cited by this paper
• Acetaminophen: acute and chronic effects on renal function.

  1996cited by this paper
• Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats.

  1996cited by this paper
• Species similarities and differences in pharmacokinetics.

  1995influential reference
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• Homeostasis of sulfate and 3'-phosphoadenosine 5'-phosphosulfate in rats after acetaminophen administration.

  1992cited by this paper
• Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy.

  1984influential reference
• Glucuronidation and biliary excretion of acetaminophen in rats.

  1984cited by this paper
• Pharmacokinetic study of the fate of acetaminophen and its conjugates in rats

  1983influential reference
• Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

  1981cited by this paper
• The effect of wheat bran and pectin on paracetamol absorption in the rat

  1979cited by this paper
• Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration

  1977cited by this paper

• Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate.

  2022cites this paper
• A PBPK model to evaluate zebrafish eleutheroembryos’ actual exposure: bisphenol A and analogs’ (AF, F, and S) case studies

  2022cites this paper
• Acetaminophen toxicity and overdose: current understanding and future directions for NAC dosing regimens

  2022cites this paper
• Mathematical modelling of a liver hollow fibre bioreactor.

  2019cites this paper
• A systems toxicology framework for improving the identification of paracetamol overdose

  2019cites this paper
• Added value of human biomonitoring in assessment of general population exposure to xenobiotics.

  2019cites this paper
• Cell cultures in drug discovery and development: The need of reliable in vitro‐in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment

  2018cites this paper
• Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications

  2017cites this paper
• A framework and case studies for evaluation of enzyme ontogeny in children’s health risk evaluation

  2017cites this paper
• Multiscale modelling approaches for assessing cosmetic ingredients safety.

  2017influential citation
• CORAL: Binary classifications (active/inactive) for drug-induced liver injury.

  2017cites this paper
• In vitro assays in natural products research – a matter of concentration and relevance to in vivo administration using resveratrol, α-mangostin/γ-mangostin and xanthohumol as examples

  2017cites this paper
• Efectos tóxicos del paracetamol en la salud humana y el ambiente

  2017cites this paper
• Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach

  2016cites this paper
• A novel approach for estimating ingested dose associated with paracetamol overdose.

  2016cites this paper
• The Need for Human Exposure Projection in the Interpretation of Preclinical In Vitro and In Vivo ADME Tox Data

  2016cites this paper
• Computational modeling of the pharmacokinetics and pharmacodynamics of selected xenobiotics

  2016influential citation
• Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations

  2016cites this paper
• Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling

  2016cites this paper
• A Liver-Centric Multiscale Modeling Framework for Xenobiotics

  2016influential citation
• Analysis of real-time mixture cytotoxicity data following repeated exposure using BK/TD models.

  2016cites this paper
• The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.

  2016cites this paper
• Perspectives for integrating human and environmental exposure assessments.

  2016cites this paper
• A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.

  2015cites this paper
• Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.

  2015cites this paper
• Physiologically Based Pharmacokinetic ( PBPK ) Modeling and Simulation Approaches : A Systematic Review of Published Models , Applications , and Model Verification s

  2015cites this paper
• BK/TD models for analyzing in vitro impedance data on cytotoxicity.

  2015cites this paper
• The SEURAT-1 approach towards animal free human safety assessment.

  2015cites this paper
• PBPK modeling for PFOS and PFOA: validation with human experimental data.

  2014cites this paper
• A physiologically based toxicokinetic model for the zebrafish Danio rerio.

  2014cites this paper
• Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity.

  2014cites this paper
• PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.

  2014cites this paper
• Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.

  2013cites this paper
• Determining Chemical Reactivity Driving Biological Activity from SMILES Transformations: The Bonding Mechanism of Anti-HIV Pyrimidines

  2013cites this paper